UBLYX
Dead / Abandoned — Abandoned — no statement of use filed (as of 13 Jun 2022)
What this means for you
This application is over — abandoned 13 Jun 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88160382
- Mark type
- Stylized text
- Filed
- 18 Oct 2018
- Published for opposition
- 12 Mar 2019
- Abandoned
- 13 Jun 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations and substances for the treatment of oncological, autoimmune and central nervous system diseases and disorders
Owner
- TG Therapeutics, New York, NY, US
- TG Therapeutics, New York, NY, US
Prosecution history
- 13 Jun 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Jun 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Nov 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2021 — SOU EXTENSION 5 GRANTED
- 01 Nov 2021 — SOU EXTENSION 5 FILED
- 01 Nov 2021 — SOU TEAS EXTENSION RECEIVED
- 06 May 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 May 2021 — SOU EXTENSION 4 GRANTED
- 04 May 2021 — SOU EXTENSION 4 FILED
- 04 May 2021 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2021 — SOU EXTENSION 3 GRANTED
- 09 Nov 2020 — SOU EXTENSION 3 FILED
- 09 Feb 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 11 Nov 2020 — NOTICE OF REVIVAL - E-MAILED